EMVision Medical Devices Ltd (ASX:EMV)

Market Cap	161.71M +5.1%
Revenue (ttm)	5.43M -32.7%
Net Income	-10.20M
EPS	-0.12
Shares Out	92.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,560
Average Volume	58,216
Open	1.770
Previous Close	1.740
Day's Range	1.710 - 1.770
52-Week Range	1.480 - 2.430
Beta	1.01
RSI	59.84
Earnings Date	May 22, 2026

About EMVision Medical Devices

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EMV

Financial Performance

In fiscal year 2025, EMVision Medical Devices's revenue was 5.05 million, a decrease of -54.97% compared to the previous year's 11.22 million. Losses were -9.81 million, 259.2% more than in 2024.